http://www.unboundmedicine.com/medline/ebm/research/aripiprazoleUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19924590/full_citation/Effectiveness_of_Intramuscular_Aripiprazole_Injection_in_Patients_with_Catatonia:_Report_on_Three_Cases_Voros V, Kovacs A, Herold R, et al. 
Effectiveness of Intramuscular Aripiprazole Injection in Patients with Catatonia: Report on Three Cases. [LETTER]
Pharmacopsychiatry 2009 Nov; 42(6):286-287.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19922371/full_citation/Rotarod_Impairment:_Catalepsy_Like_Screening_Test_for_Antipsychotic_Side_Effects_Kirschbaum KM, Hiemke C, Schmitt U 
Rotarod Impairment: Catalepsy-Like Screening Test for Antipsychotic Side Effects. [JOURNAL ARTICLE]
Int J Neurosci 2009; 119(10):1509-1522.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917149/full_citation/Aripiprazole_induced_behavioural_disturbance_related_to_impulse_control_in_a_clinical_setting_Kodama M, Hamamura T 
Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting. [JOURNAL ARTICLE]
Int J Neuropsychopharmacol 2009 Nov 17.:1-3.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19916856/full_citation/Movement_disorders_associated_with_aripiprazole_use:_a_case_series_Hall DA, Agarwal P, Griffith A, et al. 
Movement disorders associated with aripiprazole use: a case series. [Journal Article]
Int J Neurosci 2009; 119(12):2274-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19910732/full_citation/Successful_aripiprazole_augmentation_in_a_child_with_drug_resistant_obsessive_compulsive_disorder_Oztürk M, Coskun M 
Successful aripiprazole augmentation in a child with drug-resistant obsessive-compulsive disorder. [Letter]
J Clin Psychopharmacol 2009 Dec; 29(6):607-9.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19909227/full_citation/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_SelectivityMailman RB, Murthy V 
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity? [JOURNAL ARTICLE]
Curr Pharm Des 2009 Nov 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19906348/full_citation/Acute_treatment_of_pediatric_bipolar_I_disorder_manic_or_mixed_episode_with_aripiprazole:_a_randomized_double_blind_placebo_controlled_study_Findling RL, Nyilas M, Forbes RA, et al. 
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Psychiatry 2009 Oct; 70(10):1441-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19906340/full_citation/A_multicenter_randomized_double_blind_placebo_controlled_16_week_study_of_adjunctive_aripiprazole_for_schizophrenia_or_schizoaffective_disorder_inadequately_treated_with_quetiapine_or_risperidone_monotherapy_Kane JM, Correll CU, Goff DC, et al. 
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Psychiatry 2009 Oct; 70(10):1348-57.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19896900/full_citation/Dopamine_D_2__D_3__receptor_heteromers:_pharmacological_properties_and_therapeutic_significance_Maggio R, Millan MJ 
Dopamine D(2)-D(3) receptor heteromers: pharmacological properties and therapeutic significance. [JOURNAL ARTICLE]
Curr Opin Pharmacol 2009 Nov 5.
Abstract | Full Citation | Find Related Articles